nodes	percent_of_prediction	percent_of_DWPC	metapath
Atazanavir—Cytochrome P450 3A4 Inhibitors—Cyclosporine—psoriasis	0.587	1	CiPCiCtD
Atazanavir—SLCO1B3—Mycophenolate mofetil—psoriasis	0.0601	0.209	CbGbCtD
Atazanavir—ABCC1—Cyclosporine—psoriasis	0.0315	0.11	CbGbCtD
Atazanavir—SLCO1B3—Methotrexate—psoriasis	0.0241	0.0839	CbGbCtD
Atazanavir—ABCC1—Methotrexate—psoriasis	0.0167	0.058	CbGbCtD
Atazanavir—CYP3A4—Calcitriol—psoriasis	0.0134	0.0468	CbGbCtD
Atazanavir—CYP2C9—Cholecalciferol—psoriasis	0.0119	0.0415	CbGbCtD
Atazanavir—CYP3A4—Methoxsalen—psoriasis	0.0105	0.0364	CbGbCtD
Atazanavir—ABCB1—Mycophenolate mofetil—psoriasis	0.01	0.0349	CbGbCtD
Atazanavir—ABCB1—Betamethasone—psoriasis	0.0086	0.0299	CbGbCtD
Atazanavir—ABCB1—Prednisolone—psoriasis	0.00848	0.0295	CbGbCtD
Atazanavir—ABCB1—Hydrocortisone—psoriasis	0.00804	0.028	CbGbCtD
Atazanavir—ABCB1—Prednisone—psoriasis	0.00801	0.0279	CbGbCtD
Atazanavir—CYP2C9—Cyclosporine—psoriasis	0.00782	0.0272	CbGbCtD
Atazanavir—ABCB1—Cyclosporine—psoriasis	0.00759	0.0264	CbGbCtD
Atazanavir—CYP3A4—Cholecalciferol—psoriasis	0.00692	0.0241	CbGbCtD
Atazanavir—CYP3A4—Triamcinolone—psoriasis	0.006	0.0209	CbGbCtD
Atazanavir—CYP3A4—Mycophenolate mofetil—psoriasis	0.006	0.0209	CbGbCtD
Atazanavir—CYP2C9—Dexamethasone—psoriasis	0.00515	0.0179	CbGbCtD
Atazanavir—CYP3A4—Betamethasone—psoriasis	0.00515	0.0179	CbGbCtD
Atazanavir—CYP3A4—Prednisolone—psoriasis	0.00508	0.0177	CbGbCtD
Atazanavir—ABCB1—Dexamethasone—psoriasis	0.005	0.0174	CbGbCtD
Atazanavir—CYP3A4—Hydrocortisone—psoriasis	0.00482	0.0168	CbGbCtD
Atazanavir—CYP3A4—Prednisone—psoriasis	0.0048	0.0167	CbGbCtD
Atazanavir—CYP3A4—Cyclosporine—psoriasis	0.00455	0.0158	CbGbCtD
Atazanavir—ABCB1—Methotrexate—psoriasis	0.00402	0.014	CbGbCtD
Atazanavir—CYP3A4—Dexamethasone—psoriasis	0.003	0.0104	CbGbCtD
Atazanavir—Alopecia—Prednisone—psoriasis	3.81e-05	0.000302	CcSEcCtD
Atazanavir—Hepatobiliary disease—Methotrexate—psoriasis	3.79e-05	0.000301	CcSEcCtD
Atazanavir—Gastrointestinal pain—Cyclosporine—psoriasis	3.78e-05	0.000301	CcSEcCtD
Atazanavir—Loss of consciousness—Dexamethasone—psoriasis	3.78e-05	0.000301	CcSEcCtD
Atazanavir—Loss of consciousness—Betamethasone—psoriasis	3.78e-05	0.000301	CcSEcCtD
Atazanavir—Dizziness—Mycophenolic acid—psoriasis	3.78e-05	0.000301	CcSEcCtD
Atazanavir—Mental disorder—Prednisone—psoriasis	3.77e-05	0.0003	CcSEcCtD
Atazanavir—Malnutrition—Prednisone—psoriasis	3.75e-05	0.000298	CcSEcCtD
Atazanavir—Musculoskeletal discomfort—Hydrocortisone—psoriasis	3.75e-05	0.000298	CcSEcCtD
Atazanavir—Hyperhidrosis—Triamcinolone—psoriasis	3.74e-05	0.000297	CcSEcCtD
Atazanavir—Convulsion—Dexamethasone—psoriasis	3.73e-05	0.000296	CcSEcCtD
Atazanavir—Convulsion—Betamethasone—psoriasis	3.73e-05	0.000296	CcSEcCtD
Atazanavir—Feeling abnormal—Mycophenolate mofetil—psoriasis	3.72e-05	0.000296	CcSEcCtD
Atazanavir—Insomnia—Hydrocortisone—psoriasis	3.72e-05	0.000296	CcSEcCtD
Atazanavir—Hypertension—Dexamethasone—psoriasis	3.72e-05	0.000295	CcSEcCtD
Atazanavir—Hypertension—Betamethasone—psoriasis	3.72e-05	0.000295	CcSEcCtD
Atazanavir—Gastrointestinal pain—Mycophenolate mofetil—psoriasis	3.69e-05	0.000293	CcSEcCtD
Atazanavir—Urticaria—Cyclosporine—psoriasis	3.68e-05	0.000292	CcSEcCtD
Atazanavir—Myalgia—Betamethasone—psoriasis	3.66e-05	0.000291	CcSEcCtD
Atazanavir—Myalgia—Dexamethasone—psoriasis	3.66e-05	0.000291	CcSEcCtD
Atazanavir—Body temperature increased—Cyclosporine—psoriasis	3.66e-05	0.000291	CcSEcCtD
Atazanavir—Abdominal pain—Cyclosporine—psoriasis	3.66e-05	0.000291	CcSEcCtD
Atazanavir—Anxiety—Dexamethasone—psoriasis	3.65e-05	0.00029	CcSEcCtD
Atazanavir—Anxiety—Betamethasone—psoriasis	3.65e-05	0.00029	CcSEcCtD
Atazanavir—Vomiting—Mycophenolic acid—psoriasis	3.64e-05	0.000289	CcSEcCtD
Atazanavir—Discomfort—Betamethasone—psoriasis	3.62e-05	0.000288	CcSEcCtD
Atazanavir—Discomfort—Dexamethasone—psoriasis	3.62e-05	0.000288	CcSEcCtD
Atazanavir—Dyspepsia—Hydrocortisone—psoriasis	3.62e-05	0.000288	CcSEcCtD
Atazanavir—Rash—Mycophenolic acid—psoriasis	3.61e-05	0.000287	CcSEcCtD
Atazanavir—Dermatitis—Mycophenolic acid—psoriasis	3.6e-05	0.000286	CcSEcCtD
Atazanavir—Pain—Prednisolone—psoriasis	3.6e-05	0.000286	CcSEcCtD
Atazanavir—Hepatitis—Methotrexate—psoriasis	3.6e-05	0.000286	CcSEcCtD
Atazanavir—Urticaria—Mycophenolate mofetil—psoriasis	3.59e-05	0.000285	CcSEcCtD
Atazanavir—Headache—Mycophenolic acid—psoriasis	3.58e-05	0.000285	CcSEcCtD
Atazanavir—Decreased appetite—Hydrocortisone—psoriasis	3.57e-05	0.000284	CcSEcCtD
Atazanavir—Abdominal pain—Mycophenolate mofetil—psoriasis	3.57e-05	0.000284	CcSEcCtD
Atazanavir—Body temperature increased—Mycophenolate mofetil—psoriasis	3.57e-05	0.000284	CcSEcCtD
Atazanavir—Urinary tract disorder—Methotrexate—psoriasis	3.55e-05	0.000282	CcSEcCtD
Atazanavir—Gastrointestinal disorder—Hydrocortisone—psoriasis	3.55e-05	0.000282	CcSEcCtD
Atazanavir—Fatigue—Hydrocortisone—psoriasis	3.55e-05	0.000282	CcSEcCtD
Atazanavir—Urethral disorder—Methotrexate—psoriasis	3.53e-05	0.00028	CcSEcCtD
Atazanavir—Musculoskeletal discomfort—Triamcinolone—psoriasis	3.53e-05	0.00028	CcSEcCtD
Atazanavir—Pain—Hydrocortisone—psoriasis	3.52e-05	0.000279	CcSEcCtD
Atazanavir—Oedema—Dexamethasone—psoriasis	3.51e-05	0.000279	CcSEcCtD
Atazanavir—Oedema—Betamethasone—psoriasis	3.51e-05	0.000279	CcSEcCtD
Atazanavir—Insomnia—Triamcinolone—psoriasis	3.5e-05	0.000278	CcSEcCtD
Atazanavir—Infection—Betamethasone—psoriasis	3.49e-05	0.000277	CcSEcCtD
Atazanavir—Infection—Dexamethasone—psoriasis	3.49e-05	0.000277	CcSEcCtD
Atazanavir—Ill-defined disorder—Prednisone—psoriasis	3.48e-05	0.000276	CcSEcCtD
Atazanavir—Feeling abnormal—Prednisolone—psoriasis	3.47e-05	0.000276	CcSEcCtD
Atazanavir—Shock—Betamethasone—psoriasis	3.46e-05	0.000275	CcSEcCtD
Atazanavir—Shock—Dexamethasone—psoriasis	3.46e-05	0.000275	CcSEcCtD
Atazanavir—Dyspnoea—Triamcinolone—psoriasis	3.45e-05	0.000274	CcSEcCtD
Atazanavir—Nervous system disorder—Betamethasone—psoriasis	3.45e-05	0.000274	CcSEcCtD
Atazanavir—Nervous system disorder—Dexamethasone—psoriasis	3.45e-05	0.000274	CcSEcCtD
Atazanavir—Agitation—Prednisone—psoriasis	3.44e-05	0.000274	CcSEcCtD
Atazanavir—Angioedema—Prednisone—psoriasis	3.43e-05	0.000272	CcSEcCtD
Atazanavir—Hypersensitivity—Cyclosporine—psoriasis	3.41e-05	0.000271	CcSEcCtD
Atazanavir—Dyspepsia—Triamcinolone—psoriasis	3.41e-05	0.000271	CcSEcCtD
Atazanavir—Erythema multiforme—Methotrexate—psoriasis	3.4e-05	0.00027	CcSEcCtD
Atazanavir—Nausea—Mycophenolic acid—psoriasis	3.4e-05	0.00027	CcSEcCtD
Atazanavir—Hyperhidrosis—Dexamethasone—psoriasis	3.4e-05	0.00027	CcSEcCtD
Atazanavir—Hyperhidrosis—Betamethasone—psoriasis	3.4e-05	0.00027	CcSEcCtD
Atazanavir—Feeling abnormal—Hydrocortisone—psoriasis	3.39e-05	0.000269	CcSEcCtD
Atazanavir—Malaise—Prednisone—psoriasis	3.38e-05	0.000269	CcSEcCtD
Atazanavir—Eye disorder—Methotrexate—psoriasis	3.36e-05	0.000267	CcSEcCtD
Atazanavir—Gastrointestinal pain—Hydrocortisone—psoriasis	3.36e-05	0.000267	CcSEcCtD
Atazanavir—Syncope—Prednisone—psoriasis	3.36e-05	0.000267	CcSEcCtD
Atazanavir—Tinnitus—Methotrexate—psoriasis	3.36e-05	0.000267	CcSEcCtD
Atazanavir—Anorexia—Dexamethasone—psoriasis	3.35e-05	0.000266	CcSEcCtD
Atazanavir—Anorexia—Betamethasone—psoriasis	3.35e-05	0.000266	CcSEcCtD
Atazanavir—Urticaria—Prednisolone—psoriasis	3.34e-05	0.000266	CcSEcCtD
Atazanavir—Cardiac disorder—Methotrexate—psoriasis	3.34e-05	0.000265	CcSEcCtD
Atazanavir—Fatigue—Triamcinolone—psoriasis	3.34e-05	0.000265	CcSEcCtD
Atazanavir—Hypersensitivity—Mycophenolate mofetil—psoriasis	3.33e-05	0.000264	CcSEcCtD
Atazanavir—Asthenia—Cyclosporine—psoriasis	3.32e-05	0.000264	CcSEcCtD
Atazanavir—Pain—Triamcinolone—psoriasis	3.31e-05	0.000263	CcSEcCtD
Atazanavir—Loss of consciousness—Prednisone—psoriasis	3.29e-05	0.000262	CcSEcCtD
Atazanavir—Pruritus—Cyclosporine—psoriasis	3.27e-05	0.00026	CcSEcCtD
Atazanavir—Urticaria—Hydrocortisone—psoriasis	3.27e-05	0.00026	CcSEcCtD
Atazanavir—Angiopathy—Methotrexate—psoriasis	3.27e-05	0.000259	CcSEcCtD
Atazanavir—Immune system disorder—Methotrexate—psoriasis	3.25e-05	0.000258	CcSEcCtD
Atazanavir—Abdominal pain—Hydrocortisone—psoriasis	3.25e-05	0.000258	CcSEcCtD
Atazanavir—Body temperature increased—Hydrocortisone—psoriasis	3.25e-05	0.000258	CcSEcCtD
Atazanavir—Convulsion—Prednisone—psoriasis	3.25e-05	0.000258	CcSEcCtD
Atazanavir—Mediastinal disorder—Methotrexate—psoriasis	3.24e-05	0.000258	CcSEcCtD
Atazanavir—Asthenia—Mycophenolate mofetil—psoriasis	3.24e-05	0.000257	CcSEcCtD
Atazanavir—Hypertension—Prednisone—psoriasis	3.24e-05	0.000257	CcSEcCtD
Atazanavir—Musculoskeletal discomfort—Dexamethasone—psoriasis	3.2e-05	0.000254	CcSEcCtD
Atazanavir—Musculoskeletal discomfort—Betamethasone—psoriasis	3.2e-05	0.000254	CcSEcCtD
Atazanavir—Pruritus—Mycophenolate mofetil—psoriasis	3.19e-05	0.000254	CcSEcCtD
Atazanavir—Myalgia—Prednisone—psoriasis	3.19e-05	0.000254	CcSEcCtD
Atazanavir—Arthralgia—Prednisone—psoriasis	3.19e-05	0.000254	CcSEcCtD
Atazanavir—Feeling abnormal—Triamcinolone—psoriasis	3.19e-05	0.000254	CcSEcCtD
Atazanavir—Anxiety—Prednisone—psoriasis	3.18e-05	0.000253	CcSEcCtD
Atazanavir—Alopecia—Methotrexate—psoriasis	3.18e-05	0.000253	CcSEcCtD
Atazanavir—Insomnia—Betamethasone—psoriasis	3.18e-05	0.000253	CcSEcCtD
Atazanavir—Insomnia—Dexamethasone—psoriasis	3.18e-05	0.000253	CcSEcCtD
Atazanavir—Unspecified disorder of skin and subcutaneous tissue—Prednisone—psoriasis	3.17e-05	0.000252	CcSEcCtD
Atazanavir—Diarrhoea—Cyclosporine—psoriasis	3.17e-05	0.000252	CcSEcCtD
Atazanavir—Discomfort—Prednisone—psoriasis	3.15e-05	0.000251	CcSEcCtD
Atazanavir—Mental disorder—Methotrexate—psoriasis	3.15e-05	0.000251	CcSEcCtD
Atazanavir—Malnutrition—Methotrexate—psoriasis	3.13e-05	0.000249	CcSEcCtD
Atazanavir—Hypersensitivity—Prednisolone—psoriasis	3.1e-05	0.000247	CcSEcCtD
Atazanavir—Dyspepsia—Dexamethasone—psoriasis	3.09e-05	0.000246	CcSEcCtD
Atazanavir—Dyspepsia—Betamethasone—psoriasis	3.09e-05	0.000246	CcSEcCtD
Atazanavir—Diarrhoea—Mycophenolate mofetil—psoriasis	3.09e-05	0.000245	CcSEcCtD
Atazanavir—Urticaria—Triamcinolone—psoriasis	3.08e-05	0.000244	CcSEcCtD
Atazanavir—Dysgeusia—Methotrexate—psoriasis	3.07e-05	0.000244	CcSEcCtD
Atazanavir—Body temperature increased—Triamcinolone—psoriasis	3.06e-05	0.000243	CcSEcCtD
Atazanavir—Dizziness—Cyclosporine—psoriasis	3.06e-05	0.000243	CcSEcCtD
Atazanavir—Oedema—Prednisone—psoriasis	3.06e-05	0.000243	CcSEcCtD
Atazanavir—Decreased appetite—Dexamethasone—psoriasis	3.05e-05	0.000243	CcSEcCtD
Atazanavir—Decreased appetite—Betamethasone—psoriasis	3.05e-05	0.000243	CcSEcCtD
Atazanavir—Infection—Prednisone—psoriasis	3.04e-05	0.000242	CcSEcCtD
Atazanavir—Gastrointestinal disorder—Dexamethasone—psoriasis	3.03e-05	0.000241	CcSEcCtD
Atazanavir—Gastrointestinal disorder—Betamethasone—psoriasis	3.03e-05	0.000241	CcSEcCtD
Atazanavir—Back pain—Methotrexate—psoriasis	3.03e-05	0.000241	CcSEcCtD
Atazanavir—Hypersensitivity—Hydrocortisone—psoriasis	3.03e-05	0.000241	CcSEcCtD
Atazanavir—Fatigue—Dexamethasone—psoriasis	3.03e-05	0.000241	CcSEcCtD
Atazanavir—Fatigue—Betamethasone—psoriasis	3.03e-05	0.000241	CcSEcCtD
Atazanavir—Shock—Prednisone—psoriasis	3.01e-05	0.000239	CcSEcCtD
Atazanavir—Pain—Betamethasone—psoriasis	3e-05	0.000239	CcSEcCtD
Atazanavir—Pain—Dexamethasone—psoriasis	3e-05	0.000239	CcSEcCtD
Atazanavir—Nervous system disorder—Prednisone—psoriasis	3e-05	0.000238	CcSEcCtD
Atazanavir—Dizziness—Mycophenolate mofetil—psoriasis	2.98e-05	0.000237	CcSEcCtD
Atazanavir—Skin disorder—Prednisone—psoriasis	2.97e-05	0.000236	CcSEcCtD
Atazanavir—Hyperhidrosis—Prednisone—psoriasis	2.96e-05	0.000235	CcSEcCtD
Atazanavir—Asthenia—Hydrocortisone—psoriasis	2.95e-05	0.000234	CcSEcCtD
Atazanavir—Vomiting—Cyclosporine—psoriasis	2.94e-05	0.000234	CcSEcCtD
Atazanavir—Rash—Cyclosporine—psoriasis	2.92e-05	0.000232	CcSEcCtD
Atazanavir—Anorexia—Prednisone—psoriasis	2.92e-05	0.000232	CcSEcCtD
Atazanavir—Dermatitis—Cyclosporine—psoriasis	2.91e-05	0.000232	CcSEcCtD
Atazanavir—Pruritus—Hydrocortisone—psoriasis	2.91e-05	0.000231	CcSEcCtD
Atazanavir—Ill-defined disorder—Methotrexate—psoriasis	2.91e-05	0.000231	CcSEcCtD
Atazanavir—Headache—Cyclosporine—psoriasis	2.9e-05	0.00023	CcSEcCtD
Atazanavir—Feeling abnormal—Dexamethasone—psoriasis	2.89e-05	0.00023	CcSEcCtD
Atazanavir—Feeling abnormal—Betamethasone—psoriasis	2.89e-05	0.00023	CcSEcCtD
Atazanavir—Gastrointestinal pain—Betamethasone—psoriasis	2.87e-05	0.000228	CcSEcCtD
Atazanavir—Gastrointestinal pain—Dexamethasone—psoriasis	2.87e-05	0.000228	CcSEcCtD
Atazanavir—Vomiting—Mycophenolate mofetil—psoriasis	2.87e-05	0.000228	CcSEcCtD
Atazanavir—Hypersensitivity—Triamcinolone—psoriasis	2.85e-05	0.000227	CcSEcCtD
Atazanavir—Rash—Mycophenolate mofetil—psoriasis	2.85e-05	0.000226	CcSEcCtD
Atazanavir—Dermatitis—Mycophenolate mofetil—psoriasis	2.84e-05	0.000226	CcSEcCtD
Atazanavir—Headache—Mycophenolate mofetil—psoriasis	2.83e-05	0.000225	CcSEcCtD
Atazanavir—Malaise—Methotrexate—psoriasis	2.83e-05	0.000225	CcSEcCtD
Atazanavir—Diarrhoea—Hydrocortisone—psoriasis	2.81e-05	0.000224	CcSEcCtD
Atazanavir—Urticaria—Betamethasone—psoriasis	2.79e-05	0.000222	CcSEcCtD
Atazanavir—Urticaria—Dexamethasone—psoriasis	2.79e-05	0.000222	CcSEcCtD
Atazanavir—Musculoskeletal discomfort—Prednisone—psoriasis	2.79e-05	0.000222	CcSEcCtD
Atazanavir—Dizziness—Prednisolone—psoriasis	2.78e-05	0.000221	CcSEcCtD
Atazanavir—Asthenia—Triamcinolone—psoriasis	2.78e-05	0.000221	CcSEcCtD
Atazanavir—Abdominal pain—Dexamethasone—psoriasis	2.78e-05	0.000221	CcSEcCtD
Atazanavir—Body temperature increased—Dexamethasone—psoriasis	2.78e-05	0.000221	CcSEcCtD
Atazanavir—Abdominal pain—Betamethasone—psoriasis	2.78e-05	0.000221	CcSEcCtD
Atazanavir—Body temperature increased—Betamethasone—psoriasis	2.78e-05	0.000221	CcSEcCtD
Atazanavir—Insomnia—Prednisone—psoriasis	2.77e-05	0.00022	CcSEcCtD
Atazanavir—Nausea—Cyclosporine—psoriasis	2.75e-05	0.000218	CcSEcCtD
Atazanavir—Pruritus—Triamcinolone—psoriasis	2.74e-05	0.000218	CcSEcCtD
Atazanavir—Cough—Methotrexate—psoriasis	2.73e-05	0.000217	CcSEcCtD
Atazanavir—Dizziness—Hydrocortisone—psoriasis	2.72e-05	0.000216	CcSEcCtD
Atazanavir—Convulsion—Methotrexate—psoriasis	2.71e-05	0.000216	CcSEcCtD
Atazanavir—Dyspepsia—Prednisone—psoriasis	2.69e-05	0.000214	CcSEcCtD
Atazanavir—Nausea—Mycophenolate mofetil—psoriasis	2.68e-05	0.000213	CcSEcCtD
Atazanavir—Chest pain—Methotrexate—psoriasis	2.67e-05	0.000212	CcSEcCtD
Atazanavir—Arthralgia—Methotrexate—psoriasis	2.67e-05	0.000212	CcSEcCtD
Atazanavir—Myalgia—Methotrexate—psoriasis	2.67e-05	0.000212	CcSEcCtD
Atazanavir—Decreased appetite—Prednisone—psoriasis	2.66e-05	0.000211	CcSEcCtD
Atazanavir—Rash—Prednisolone—psoriasis	2.65e-05	0.000211	CcSEcCtD
Atazanavir—Dermatitis—Prednisolone—psoriasis	2.65e-05	0.000211	CcSEcCtD
Atazanavir—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—psoriasis	2.65e-05	0.000211	CcSEcCtD
Atazanavir—Fatigue—Prednisone—psoriasis	2.64e-05	0.00021	CcSEcCtD
Atazanavir—Headache—Prednisolone—psoriasis	2.64e-05	0.00021	CcSEcCtD
Atazanavir—Discomfort—Methotrexate—psoriasis	2.64e-05	0.000209	CcSEcCtD
Atazanavir—Constipation—Prednisone—psoriasis	2.62e-05	0.000208	CcSEcCtD
Atazanavir—Vomiting—Hydrocortisone—psoriasis	2.61e-05	0.000208	CcSEcCtD
Atazanavir—Rash—Hydrocortisone—psoriasis	2.59e-05	0.000206	CcSEcCtD
Atazanavir—Dermatitis—Hydrocortisone—psoriasis	2.59e-05	0.000206	CcSEcCtD
Atazanavir—Confusional state—Methotrexate—psoriasis	2.58e-05	0.000205	CcSEcCtD
Atazanavir—Headache—Hydrocortisone—psoriasis	2.58e-05	0.000205	CcSEcCtD
Atazanavir—Dizziness—Triamcinolone—psoriasis	2.56e-05	0.000203	CcSEcCtD
Atazanavir—Infection—Methotrexate—psoriasis	2.54e-05	0.000202	CcSEcCtD
Atazanavir—Feeling abnormal—Prednisone—psoriasis	2.52e-05	0.0002	CcSEcCtD
Atazanavir—Asthenia—Betamethasone—psoriasis	2.52e-05	0.0002	CcSEcCtD
Atazanavir—Asthenia—Dexamethasone—psoriasis	2.52e-05	0.0002	CcSEcCtD
Atazanavir—Nervous system disorder—Methotrexate—psoriasis	2.51e-05	0.000199	CcSEcCtD
Atazanavir—Gastrointestinal pain—Prednisone—psoriasis	2.5e-05	0.000199	CcSEcCtD
Atazanavir—Nausea—Prednisolone—psoriasis	2.5e-05	0.000199	CcSEcCtD
Atazanavir—Pruritus—Betamethasone—psoriasis	2.49e-05	0.000198	CcSEcCtD
Atazanavir—Pruritus—Dexamethasone—psoriasis	2.49e-05	0.000198	CcSEcCtD
Atazanavir—Skin disorder—Methotrexate—psoriasis	2.48e-05	0.000197	CcSEcCtD
Atazanavir—Hyperhidrosis—Methotrexate—psoriasis	2.47e-05	0.000196	CcSEcCtD
Atazanavir—Vomiting—Triamcinolone—psoriasis	2.46e-05	0.000196	CcSEcCtD
Atazanavir—Nausea—Hydrocortisone—psoriasis	2.44e-05	0.000194	CcSEcCtD
Atazanavir—Rash—Triamcinolone—psoriasis	2.44e-05	0.000194	CcSEcCtD
Atazanavir—Dermatitis—Triamcinolone—psoriasis	2.44e-05	0.000194	CcSEcCtD
Atazanavir—Anorexia—Methotrexate—psoriasis	2.44e-05	0.000194	CcSEcCtD
Atazanavir—Urticaria—Prednisone—psoriasis	2.43e-05	0.000193	CcSEcCtD
Atazanavir—Headache—Triamcinolone—psoriasis	2.43e-05	0.000193	CcSEcCtD
Atazanavir—Body temperature increased—Prednisone—psoriasis	2.42e-05	0.000192	CcSEcCtD
Atazanavir—Abdominal pain—Prednisone—psoriasis	2.42e-05	0.000192	CcSEcCtD
Atazanavir—Diarrhoea—Dexamethasone—psoriasis	2.4e-05	0.000191	CcSEcCtD
Atazanavir—Diarrhoea—Betamethasone—psoriasis	2.4e-05	0.000191	CcSEcCtD
Atazanavir—Musculoskeletal discomfort—Methotrexate—psoriasis	2.33e-05	0.000185	CcSEcCtD
Atazanavir—Dizziness—Betamethasone—psoriasis	2.32e-05	0.000185	CcSEcCtD
Atazanavir—Dizziness—Dexamethasone—psoriasis	2.32e-05	0.000185	CcSEcCtD
Atazanavir—Insomnia—Methotrexate—psoriasis	2.31e-05	0.000184	CcSEcCtD
Atazanavir—Nausea—Triamcinolone—psoriasis	2.3e-05	0.000183	CcSEcCtD
Atazanavir—Dyspnoea—Methotrexate—psoriasis	2.28e-05	0.000181	CcSEcCtD
Atazanavir—Somnolence—Methotrexate—psoriasis	2.27e-05	0.000181	CcSEcCtD
Atazanavir—Hypersensitivity—Prednisone—psoriasis	2.25e-05	0.000179	CcSEcCtD
Atazanavir—Dyspepsia—Methotrexate—psoriasis	2.25e-05	0.000179	CcSEcCtD
Atazanavir—Vomiting—Dexamethasone—psoriasis	2.23e-05	0.000178	CcSEcCtD
Atazanavir—Vomiting—Betamethasone—psoriasis	2.23e-05	0.000178	CcSEcCtD
Atazanavir—Decreased appetite—Methotrexate—psoriasis	2.22e-05	0.000177	CcSEcCtD
Atazanavir—Rash—Dexamethasone—psoriasis	2.22e-05	0.000176	CcSEcCtD
Atazanavir—Rash—Betamethasone—psoriasis	2.22e-05	0.000176	CcSEcCtD
Atazanavir—Dermatitis—Dexamethasone—psoriasis	2.21e-05	0.000176	CcSEcCtD
Atazanavir—Dermatitis—Betamethasone—psoriasis	2.21e-05	0.000176	CcSEcCtD
Atazanavir—Gastrointestinal disorder—Methotrexate—psoriasis	2.21e-05	0.000175	CcSEcCtD
Atazanavir—Fatigue—Methotrexate—psoriasis	2.2e-05	0.000175	CcSEcCtD
Atazanavir—Headache—Dexamethasone—psoriasis	2.2e-05	0.000175	CcSEcCtD
Atazanavir—Headache—Betamethasone—psoriasis	2.2e-05	0.000175	CcSEcCtD
Atazanavir—Asthenia—Prednisone—psoriasis	2.2e-05	0.000174	CcSEcCtD
Atazanavir—Pain—Methotrexate—psoriasis	2.19e-05	0.000174	CcSEcCtD
Atazanavir—Pruritus—Prednisone—psoriasis	2.16e-05	0.000172	CcSEcCtD
Atazanavir—Feeling abnormal—Methotrexate—psoriasis	2.11e-05	0.000167	CcSEcCtD
Atazanavir—Diarrhoea—Prednisone—psoriasis	2.09e-05	0.000166	CcSEcCtD
Atazanavir—Gastrointestinal pain—Methotrexate—psoriasis	2.09e-05	0.000166	CcSEcCtD
Atazanavir—Nausea—Betamethasone—psoriasis	2.09e-05	0.000166	CcSEcCtD
Atazanavir—Nausea—Dexamethasone—psoriasis	2.09e-05	0.000166	CcSEcCtD
Atazanavir—Urticaria—Methotrexate—psoriasis	2.03e-05	0.000161	CcSEcCtD
Atazanavir—Dizziness—Prednisone—psoriasis	2.02e-05	0.000161	CcSEcCtD
Atazanavir—Body temperature increased—Methotrexate—psoriasis	2.02e-05	0.000161	CcSEcCtD
Atazanavir—Abdominal pain—Methotrexate—psoriasis	2.02e-05	0.000161	CcSEcCtD
Atazanavir—Vomiting—Prednisone—psoriasis	1.95e-05	0.000155	CcSEcCtD
Atazanavir—Rash—Prednisone—psoriasis	1.93e-05	0.000153	CcSEcCtD
Atazanavir—Dermatitis—Prednisone—psoriasis	1.93e-05	0.000153	CcSEcCtD
Atazanavir—Headache—Prednisone—psoriasis	1.92e-05	0.000152	CcSEcCtD
Atazanavir—Hypersensitivity—Methotrexate—psoriasis	1.88e-05	0.00015	CcSEcCtD
Atazanavir—Asthenia—Methotrexate—psoriasis	1.83e-05	0.000146	CcSEcCtD
Atazanavir—Nausea—Prednisone—psoriasis	1.82e-05	0.000144	CcSEcCtD
Atazanavir—Pruritus—Methotrexate—psoriasis	1.81e-05	0.000144	CcSEcCtD
Atazanavir—Diarrhoea—Methotrexate—psoriasis	1.75e-05	0.000139	CcSEcCtD
Atazanavir—Dizziness—Methotrexate—psoriasis	1.69e-05	0.000134	CcSEcCtD
Atazanavir—Vomiting—Methotrexate—psoriasis	1.63e-05	0.000129	CcSEcCtD
Atazanavir—Rash—Methotrexate—psoriasis	1.61e-05	0.000128	CcSEcCtD
Atazanavir—Dermatitis—Methotrexate—psoriasis	1.61e-05	0.000128	CcSEcCtD
Atazanavir—Headache—Methotrexate—psoriasis	1.6e-05	0.000127	CcSEcCtD
Atazanavir—Nausea—Methotrexate—psoriasis	1.52e-05	0.000121	CcSEcCtD
